已收录 268921 条政策
 政策提纲
  • 暂无提纲
Immunotherapy with a standardized Dermatophagoides pteronyssinus extract .6. Specific immunotherapy prevents the onset of new sensitizations in children
[摘要] Background: Tile natural history of allergic sensitization is complex and poorly understood, A prospective nonrandomized study was carried out in a population of asthmatic children younger than 6 gears of age whose only allergic sensitivity was to house dust mites (HDMs). Objectives: The study was designed to determine whether specific immunotherapy (SIT) with standardized allergen extracts could prevent the development of new sensitizations over a 3-year follow-up survey. Methods: We studied 22 children monosensitized to HDM who were receiving SIT with standardized allergen extracts and 22 other age-matched control subjects who mere monosensitized to HDM. The initial investigation included a full clinical history, skin tests with a panel of standardized allergens, and the measurement of allergen-specific IgE, depending on the results of skin tests. Children were followed up on an annual basis for 3 years, and the development of new sensitizations in each group was recorded. Results: Ten of 22 children monosensitized to BDM who were receiving SIT did not have new sensitivities compared with zero of 22 children in the control group (p = 0.001, chi square test). Conclusions: This study suggests that SIT in children monosensitized to HDM alters the natural course of allergy in preventing the development of new sensitizations.
[发布日期] 1997-04-01 [发布机构] 
[效力级别]  [学科分类] 
[关键词] allergy;IgE;immunotherapy;natural course [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文